| 459.92 0.26 (0.06%) | 08-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 537.27 | 1-year : | 627.54 |
| Resists | First : | 460 | Second : | 537.27 |
| Pivot price | 459.74  |
|||
| Supports | First : | 458.45 | Second : | 457.5 |
| MAs | MA(5) : | 459.92 | MA(20) : | 459.44 |
| MA(100) : | 447.32 |
MA(250) : | 402.85  |
|
| MACD | MACD : | 0.8 |
Signal : | 0.9 |
| %K %D | K(14,3) : | 93.2 |
D(3) : | 94 |
| RSI | RSI(14): 64.4 | |||
| 52-week | High : | 503.23 | Low : | 274.98 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ATRI ] has closed below upper band by 33.7%. Bollinger Bands are 96.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 61 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 460.99 - 463.26 | 463.26 - 465.1 |
| Low: | 453.48 - 456.65 | 456.65 - 459.22 |
| Close: | 455.54 - 460.28 | 460.28 - 464.12 |
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Fri, 09 Aug 2024
Atrion's (ATRI) Q2 Earnings Plummet Y/Y on Nordson Merger Costs - Yahoo Finance
Tue, 28 May 2024
Nordson to bolster medical portfolio through $800 million acquisition - Crain's Cleveland Business
Fri, 10 May 2024
Atrion Corp (ATRI) Reports Mixed Q1 2024 Results Amid Revenue Growth and Margin Pressures - Yahoo Finance
Thu, 29 Feb 2024
Atrion Corp (ATRI) Faces Headwinds: Full Year Revenue and Net Income Decline - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 23.3 (%) |
| Held by Institutions | 71.8 (%) |
| Shares Short | 44 (K) |
| Shares Short P.Month | 60 (K) |
| EPS | 7.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 135.72 |
| Profit Margin | 6.9 % |
| Operating Margin | 1.1 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 5.2 % |
| Qtrly Rev. Growth | 11.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 103.18 |
| EBITDA (p.s.) | 18.46 |
| Qtrly Earnings Growth | -94 % |
| Operating Cash Flow | 39 (M) |
| Levered Free Cash Flow | 26 (M) |
| PE Ratio | 64.5 |
| PEG Ratio | 0 |
| Price to Book value | 3.38 |
| Price to Sales | 4.45 |
| Price to Cash Flow | 20.88 |
| Dividend | 2.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|